T-cell responses have been identified from regressing cancer patients to differentiation antigens such as tyrosinase-related protein (TRP) 2 and gp100 and the cancer testis antigens NY-ESO-1 and the MAGE family [36–38]. Here, PMEL is linked to cancer.